Functional Expression of Sodium Iodide Symporter (NIS) in Human Breast Cancer Tissue

By Upadhyay G.  

Breast Cancer Research and Treatment, Vol. 77, Iss. 2, 2003-01 ,pp. : 157-165

Springer Publishing Company

Access to resources Recommend Favorite

The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)

By Fortunati N.   Catalano M.   Marano F.   Mugoni V.   Pugliese M.   Bosco O.   Mainini F.   Boccuzzi G.  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 667-675

Springer Publishing Company

Access to resources Recommend Favorite

Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer

By              

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 59-66

Spandidos Publications

Access to resources Recommend Favorite

Radiofrequency induction on sodium/iodide symporter expression of thyroid cancer

By Tian Youxin   Liu Qinjiang   Ni Yaqiong  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 11, 2013-11 ,pp. : 516-520

Springer Publishing Company

Access to resources Recommend Favorite

131I therapy mediated by sodium/iodide symporter combined with kringle 5 has a synergistic therapeutic effect on glioma

By                

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 691-698

Spandidos Publications

Access to resources Recommend Favorite